Cochlear Implants
APAC · 1 shared keyword
APAC Myopia Control Market Industry Trends and Forecast to 2034: Segmented by (Product, Age, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
APAC · 2024–2034 · estimates
Market Dashboard
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Estimate 2024
$663.6 Mn
Estimated value
Estimate 2025
$770.5 Mn
19.4% of the global market
Projected 2034
$2.95 Bn 283.3%
Adds $2.18 Bn over 9 forecast years
CAGR 2025–2034
16.1%
Faster than 86% of 173 Medical Devices markets here
Key players
5
- APAC is 19.42% of the global market.
- Among regions, the largest is North America at $2.04 Bn.
- Fastest growing: Latin America at 16.3% a year.
- APAC ranks 2nd of 6 by size among regions.
Market size projection
APACSource: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
Value added each year
$2.18 Bn total, 2026–2034
Year-by-year market size, 2024–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $663.6 Mn | — | — |
| 2025 (base) | $770.5 Mn | +$106.8 Mn | — |
| 2026 (forecast) | $894.5 Mn | +$124.0 Mn | +16.1% |
| 2027 (forecast) | $1.04 Bn | +$144.0 Mn | +34.8% |
| 2028 (forecast) | $1.21 Bn | +$167.2 Mn | +56.5% |
| 2029 (forecast) | $1.40 Bn | +$194.1 Mn | +81.7% |
| 2030 (forecast) | $1.63 Bn | +$225.4 Mn | +110.9% |
| 2031 (forecast) | $1.89 Bn | +$261.7 Mn | +144.9% |
| 2032 (forecast) | $2.19 Bn | +$303.8 Mn | +184.3% |
| 2033 (forecast) | $2.54 Bn | +$352.7 Mn | +230.1% |
| 2034 (forecast) | $2.95 Bn | +$409.5 Mn | +283.3% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
Same market worldwide
By geography
- Global $3.97 Bn
- North America $2.04 Bn
-
US
$1.84 Bn
- APAC (this report) $770.5 Mn
- Europe $637.6 Mn
-
Canada
$305.9 Mn
-
China
$284.4 Mn
-
Japan
$237.9 Mn
- Latin America $203.0 Mn
- Middle East $172.0 Mn
-
Germany
$132.2 Mn
-
UK
$107.2 Mn
-
Brazil
$103.7 Mn
-
France
$95.8 Mn
-
Italy
$81.8 Mn
-
Spain
$80.3 Mn
-
Ecuador
$77.5 Mn
-
India
$70.0 Mn
-
Saudi Arabia
$60.2 Mn
-
Mexico
$58.9 Mn
- Africa $53.6 Mn
-
New Zealand
$43.0 Mn
-
Australia
$42.2 Mn
-
Russia
$40.1 Mn
-
South Africa
$28.0 Mn
-
UAE
$17.7 Mn
-
Philippines
$10.0 Mn
-
Egypt
$9.9 Mn
-
Malaysia
$6.9 Mn
-
Hong Kong
$6.3 Mn
-
Singapore
$5.5 Mn
-
Thailand
$5.2 Mn
-
Kenya
$2.8 Mn
The APAC Myopia Control Market Analysis Executive Summary
Myopia control slows short-sightedness getting worse in children, using special glasses, contact lenses and eye drops.
Key segments of the myopia Control market include product (Myopia Control Spectacle Lenses, Orthokeratology Lenses and Soft Multifocal Contact Lenses) and age (Children and Teenagers).
APAC Myopia Control Market Dynamics
Market Growth Drivers
An ageing population, more people with diabetes and long-term conditions, better treatments and wider access to specialist care are driving the myopia Control market.
Opportunity
Longer-acting treatments, home-based care and screening in emerging markets give the myopia Control market room to grow.
Market Restraints
High costs of new treatments, specialist shortages, low awareness and limited reimbursement in some countries hold back the myopia Control market.
Competitive Landscape for Myopia Control Market in APAC
The myopia Control market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Key Players
Healthcare Policies and Regulatory Landscape for Myopia Control Market in APAC
Policy changes and Reimbursement scenario
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how myopia Control products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in APAC.
From our blog
Eye Health Supplements: Screens, Ageing and Vision2.2 billion people have a vision impairment. One supplement formula has strong trial evidence, but only for a…
From Melghat, With Hope: How a Tribal Region is Redefining Newborn CareLow-cost digital tools empower tribal nurses, cutting newborn deaths through innovation